ANAHEIM, Calif.—Bluestar Silicones USA Corp. will expand its presence in the global healthcare market by supporting select long-term implant applications.
The firm said its facility in York, S.C., will be its global center for the company's implant-grade liquid silicone rubber, high consistency rubber and room temperature vulcanized rubber. The facility opened in 2012 and includes state-of-the-art clean rooms and enhanced systems.
"Focused long-term growth in the implant market is a natural evolution for Bluestar Silicones, said Bluestar Silicones CEO Pascal Chalvon Demersay. "We have a strong global base in healthcare, and now, with our new cutting-edge facility in York, we are well-positioned to build upon the momentum we've gained."
Christopher York, president of Bluestar Silicones North America, said the York facility is the first milestone in the implementation of the firm's 10-year strategic plan to position Bluestar Silicones as a significant silicones player in the North American and global healthcare markets.
"Our goal is to be the most responsive partner in the marketplace," York said. "We are investing in people, products and our workships, building a functional expertise that customers appreciate and trust."
Bluestar Silicones is a $650 million worldwide silicones raw material provider, headquartered in Lyon, France.